期刊文献+

丙型肝炎治疗的多因素分析 被引量:2

ANALYSIS FOR THE TREATMENT OF HEPATITIS C BY MULTIPLE STEPWISE REGRESSION
下载PDF
导出
摘要 目的探讨丙型肝炎患者的治疗及预后。方法对收治的87例患者进行多因素分析。结果总有效率为66.67%,无应答和恶化占33.33%。有明确血清暴露史的预后较好,可能与病史明确,病程较短有关。并发其它慢性疾病者疗效较差,与机体既往健康状况有关。干扰素治疗有效,且与疗程呈正相关。结论建议有输血等血清暴露史者,应定期检测血清HCV标志物,以便及时发现HCV感染,早期使用干扰素,效果较好。 ObjectiveTo analyze the affecting factors on the treatment of hepatitis C.MethodsSeven variates (sex,age, clinical courses,etc.included)on the treatment of hepatitis C were analysed with multiple regression analysis.ResultsThe total clinical efficacy rate was 66.6 % (58/87) in the series. The clinical treatment was more effective in the cases with sero exposure than those without sero exposure.The reason for the difference may be the relatively short history of HCV infection.Failure in the treatment was usually found in the patients complicated with other diseases such as diabetes,heart or brain diseases and malignant tumor etc. Interferon was effective in the treatment of hepatitis C and its treating was related with the course of treatment. ConclusionIt is suggested that the marker of HCV should be examined in the patients with sero exposure,so that the infection of HCV is found in time,and the treatment is more effective in the patients in which the interferon was used earlier.
出处 《河北医科大学学报》 CAS 1999年第2期85-86,共2页 Journal of Hebei Medical University
关键词 丙型肝炎 干扰素 药物疗法 hepatitic C/ther interferon ALFA 2B/ther use blood transfusion multiphasic screening
  • 相关文献

参考文献6

二级参考文献9

  • 1Lin R,J Med,1991年,21卷,389页
  • 2Cha T A,Proceedings of the National Academy of Sciences of the U.S.A,1992年,89卷,7144页
  • 3张东华,上海第二医科大学学报,1992年,14卷,195页
  • 4Wang J T,J Infect Dis,1992年,166卷,1167页
  • 5盛瑞媛,世界医学,1996年,1卷,20页
  • 6Tong M J,J Med,1995年,332卷,1463页
  • 7范小玲,中华传染病杂志,1995年,13卷,129页
  • 8高志良,中华传染病杂志,1994年,12卷,104页
  • 9王淑萍,中华流行病学杂志,1994年,15卷,71页

共引文献77

同被引文献43

  • 1韩悦 石有昌 等.丙型肝炎病毒血清分型的研究[J].实用肝脏病杂志,1998,3:139-141.
  • 2孙谢文.丙型肝炎病毒血清分型与基因分型的探讨[J].河北医科大学学报,1997,18:60-62.
  • 3Blatt LM, Mutchnick MG, Tong MJ, et al. Assessment of hepatitis C virus RNA and genotype from 6807 patients with chronic hepatitis C in the United State[J].J Viral Hepat,2000,7(3):196-202.
  • 4Kasahara A, Hayashi N. Hiramatsu N, et al. Ability of prolonged interferon treatment to suppress relapse after cessation of therapy in patients with chronic hepatitis C: a multicenter randomized controlled trial [J]. Hepatology, 1995,21 ( 2 ) :291.
  • 5Orito E, Mezokami M, Suzuki K, et al, Loss of serm HCV RNA at week 4 of interferon-α therapy is associated more favorable long-term response in patients with chronic hepatitis C[J]. J Med Virol,1995,46(2):109.
  • 6Kanai K, Kako M. Aikawa T, et al. Clearance of serum hepatitis C virus RNA after interferon therapy in relation to virus genotype[J]. Liver, 1995,15(4) : 185.
  • 7Neumann AU, Lam NP, Dahari H, et al. Hepatitis C viral dynamics in vivo and antiviral efficacy of interferon-alpha therapy[J]. Science[NLM-Medline], 1998,282 (5386) : 103-107.
  • 8Neumann AU. Early HCV kinetics and baseline factors in response to consensus interferon[C], a satellite symposium at the 35thannual meeting of the European Association for the study of the liver. April 30,2000, Rotterdam, The Netherlands.
  • 9Tong MJ, Reddy R, Lee WM, et al, Treatment of chronic hepatitis C with conesnsus interferon: A multicenter, randomized, controlled trial[J]. Hepatology, 1997,26 : 747-754.
  • 10Fukutomi T, Nakamuta M, Fukutomi M, et al. Decline of hepatitis C virus load in serum during the first 24 h after administration of interferon-beta as the efficacy of therapy[J]. J Hepatol, 2001,34(1) :100-107.

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部